The evolving burden of HIV infection compared with other chronic diseases in northern Italy

HIV Medicine

Volumn 12, Issue 3, 2011, Pages 129-137

  Magoni, M ^a   Scarcella, C ^a   Vassallo, F ^a   Lonati, F ^a   Carosi, G ^b   Castelnuovo, F ^c   Quiros Roldan, E ^b   Albini, L ^b   Gennaro, N ^d   Bishai, D ^e   Tramarin, A ^d   Torti, C ^b  

^a Local Health Unit of Brescia   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c SPEDALI CIVILI   (Italy)

^d Health Agency of the Veneto Region   (Italy)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cost; Health resource use; Highly active antiretroviral therapy; Public health

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC LIVER DISEASE; CHRONIC LUNG DISEASE; COMORBIDITY; COMPARATIVE STUDY; COST OF ILLNESS; DATA BASE; DIABETES MELLITUS; DUODENUM DISEASE; ESOPHAGUS DISEASE; FEMALE; HEALTH CARE; HEALTH CARE UTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MENTAL DISEASE; NEOPLASM; NEUROPATHY; OPPORTUNISTIC INFECTION; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; STOMACH DISEASE; SURGICAL PATIENT;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHRONIC DISEASE; COSTS AND COST ANALYSIS; FEMALE; HEALTH CARE COSTS; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; ITALY; MALE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS;

EID: 79551581787     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2010.00861.x     Document Type: Article

References (19)

1. Hogg R, Lima V, Sterne JA et al. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Antiretroviral Therapy Cohort Collaboration. Lancet 2008; 372: 293-299.
2. Lewden C, May T, Rosenthal E et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: the "Mortalitè 2000 and 2005"surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr 2008; 48: 590-598.
3. Phillips AN, Neaton J, Lundgren JD. The role of HIV in serious diseases other than AIDS. AIDS 2008; 22: 2409-2418.
4. Hubben GA, Bishai D, Pechlivanoglou P et al. The societal burden of HIV in Northern Italy: an analysis of costs and quality of life. AIDS Care 2008; 20: 449-455.
5. Gonzalo T, García Goñi M, Muñoz-Fernández MA. Socio-economic impact of antiretroviral treatment in HIV patients. An economic review of cost savings after introduction of HAART. AIDS Rev 2009; 11: 79-90.
6. Flessa S, Marschall P. Socio-economic impact of antiviral intervention. Handb Exp Pharmacol 2009; 189: 347-374.
7. Floridia M, Ravizza M, Tamburrini E et al. Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy. Epidemiol Infect 2006; 134: 1120-1127.
8. Izzo I, Scarcella C, Vassallo F et al. Prevalence, incidence and characteristics of the HIV population in the Brescia province by a composite database: results of the SERIHA study. Infection 2009; 37: 104.
9. World Health Organization. International classification of diseases: [9th] ninth revision, basic tabulation list with alphabetic index. Geneva 1978. ISBN: 9241541334. Available at ; (accessed 28 April 2010).
10. Guidelines for ATC classification and DDD assignment, 5th edition. WHO Collaborating Centre for Drug Statistic Methodology, Oslo 2002. Available at (accessed 28 April 2010).
11. World Health Organization, Collaborative Centre for Drug Statistics Methodology. ATC/DDD, definition and general consideration. Available at (accessed 28 April 2010).
12. Analysis Group of Pan American Health Organization's Special Program for Health Analysis. Standardization: a classic epidemiological method for the comparison of rates. Epidemiol Bull 2002; 23: 9-12. Available at (accessed 28 April 2010).
13. Breslow NE, Day NE. Statistical Methods in Cancer Research. Lyon: WHO-IARC. Oxford University Press, 1987: 69-70.
14. STATA. Data analysis and statistical software. Available at (accessed 28 April 2010).
15. Notiziario dell'Istituto Superiore di Sanità. Aggiornamento dei casi di AIDS e delle nuove diagnosi di infezione da HIV in Italia al 31 Dicembre 2007. Available at (accessed 28 April 2010).
16. Crum-Cianflone N, Huppler Hullsiek K, Marconi V et al. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS 2009; 23: 41-50.
17. Krentz HB, Gill MJ. Cost of medical care for HIV-infected patients within a regional population from 1997 to 2006. HIV Med 2008; 9: 721-730.
18. Harling G, Wood R. The evolving cost of HIV in South Africa: changes in health care cost with duration on antiretroviral therapy for public sector patients. J Acquir Immune Defic Syndr 2007; 45: 348-354.
19. Torti C, Casari S, Palvarini L et al. Modifications of health resource use in Italy after introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmacoeconomic implications in a population-based setting. Health Policy 2003; 65: 261-267.